Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Study to Prospectively Assess Baseline Status and Disease Progression in Male Children With X-Linked Adrenoleukodystrophy

NCT03278899 is registered in ClinicalTrials.gov with NeuroVia, Inc. as lead sponsor.

NCT NCT03278899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03278899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Study to Prospectively Assess Baseline Status and Disease Progression in Male Children With X-Linked Adrenoleukodystrophy
Lead sponsor
NeuroVia, Inc.
Phase
Observational
Overall status
Unknown status
Start date
February 16, 2018
Completion date
June 1, 2021
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked adrenoleukodystrophy